PSAP and LIMP-2 Dysfunctions

Eleonora Pavan,Paolo Peruzzo,Silvia Cattarossi,Natascha Bergamin,Andrea Bordugo,Annalisa Sechi,Maurizio Scarpa,Jessica Biasizzo,Fabiana Colucci,Andrea Dardis
DOI: https://doi.org/10.3390/ijms25126615
IF: 5.6
2024-06-17
International Journal of Molecular Sciences
Abstract:Glucocerebrosidase (GCase) is a lysosomal enzyme that catalyzes the breakdown of glucosylceramide in the presence of its activator saposin C (SapC). SapC arises from the proteolytical cleavage of prosaposin (encoded by PSAP gene), which gives rise to four saposins. GCase is targeted to the lysosomes by LIMP-2, encoded by SCARB2 gene. GCase deficiency causes Gaucher Disease (GD), which is mainly due to biallelic pathogenetic variants in the GCase-encoding gene, GBA1. However, impairment of GCase activity can be rarely caused by SapC or LIMP-2 deficiencies. We report a new case of LIMP-2 deficiency and a new case of SapC deficiency (missing all four saposins, PSAP deficiency), and measured common biomarkers of GD and GCase activity. Glucosylsphingosine and chitotriosidase activity in plasma were increased in GCase deficiencies caused by PSAP and GBA1 mutations, whereas SCARB2-linked deficiency showed only Glucosylsphingosine elevation. GCase activity was reduced in fibroblasts and leukocytes: the decrease was sharper in GBA1- and SCARB2-mutant fibroblasts than PSAP-mutant ones; LIMP-2-deficient leukocytes displayed higher residual GCase activity than GBA1-mutant ones. Finally, we demonstrated that GCase mainly undergoes proteasomal degradation in LIMP-2-deficient fibroblasts and lysosomal degradation in PSAP-deficient fibroblasts. Thus, we analyzed the differential biochemical profile of GCase deficiencies due to the ultra-rare PSAP and SCARB2 biallelic pathogenic variants in comparison with the profile observed in GBA1-linked GCase deficiency.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper attempts to address the biochemical differences between glucocerebrosidase (GCase) deficiency caused by biallelic variants in the PSAP and SCARB2 genes and Gaucher Disease (GD) caused by mutations in the GBA1 gene. ### Main Research Content: 1. **Case Reports**: - Reported two new cases of LIMP-2 deficiency (one of which was previously reported) and one new case of PSAP deficiency (resulting in the loss of all four saposins). - GCase activity measurements and common GD biomarkers were tested in these cases. 2. **Biochemical Analysis**: - Found elevated levels of glucosylsphingosine (GlcSph) and chitotriosidase activity in the plasma of GCase deficiency patients. - SCARB2-related defects showed only elevated GlcSph levels, while PSAP and GBA1 mutations showed elevations in both. - In fibroblasts and leukocytes, GCase activity was reduced, but GCase activity in LIMP-2 deficient leukocytes was higher than in GBA1 mutant leukocytes. 3. **Protein Expression and Degradation Pathway Analysis**: - It was found that in LIMP-2 deficient fibroblasts, GCase is primarily degraded via the proteasomal pathway; whereas in PSAP deficient fibroblasts, GCase is mainly degraded via the lysosomal pathway. 4. **Cholesterol Metabolism Analysis**: - Observed some degree of cholesterol accumulation in PSAP and LIMP-2 deficient fibroblasts, suggesting that these deficiencies may lead to cholesterol metabolism disorders. ### Summary: This paper provides detailed biochemical and cellular analyses of rare GCase deficiency cases caused by biallelic variants in the PSAP and SCARB2 genes, revealing significant differences from Gaucher Disease caused by GBA1 gene mutations. This provides important experimental evidence for further understanding these diseases.